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ABSTRACT Homotetrameric proteins can assemble by several different pathways, but have only been observed to use one,
in which two monomers associate to form a homodimer, and then two homodimers associate to form a homotetramer. To
determine why this pathway should be so uniformly dominant, we have modeled the kinetics of tetramerization for the possible
pathways as a function of the rate constants for each step. We have found that competition with the other pathways, in which
homotetramers can be formed either by the association of two different types of homodimers or by the successive addition of
monomers to homodimers and homotrimers, can cause substantial amounts of protein to be trapped as intermediates of the
assembly pathway. We propose that this could lead to undesirable consequences for an organism, and that selective pressure
may have caused homotetrameric proteins to evolve to assemble by a single pathway.
INTRODUCTION
Many proteins must be homotetrameric to be functional.
Prominent examples include transcription factors (e.g., p53)
(Friedman et al., 1993), transport proteins (e.g., trans-
thyretin) (Blake et al., 1974), potassium channels (Deutsch,
2002; Miller, 2000), water channels (Fujiyoshi et al., 2002),
and many enzymes (e.g., the catalases (Zamocky and Koller,
1999), several dehydrogenases (Adams et al., 1970; Au et al.,
1999; Buehner et al., 1974; Esposito et al., 2002; Kim et al.,
1993; Ramaswamy et al., 1994), phosphofructokinase
(Rypniewski and Evans, 1989), and phosphoglycerate
mutase (Campbell et al., 1974), among others). In fact, it
has been reported that ;17% of the proteins from
Escherichia coli in the SWISS-PROT database are homo-
tetramers (Goodsell and Olson, 2000). There has con-
sequently been great interest in the mechanism of
homotetramer formation, but the assembly kinetics of
homotetramers are more complicated than those of homo-
dimers or homotrimers because tetramerization can occur by
several different pathways. For homotetramers that are
‘‘dimers of dimers’’, that is, those that have two distinct
interfaces, the possibilities (ignoring any unimolecular
folding or reorganization steps) are illustrated in Fig. 1.
Starting from monomer (X), the ﬁrst step involves the
formation of one of the two possible homodimers, denoted
‘‘a’’ and ‘‘b’’ in Fig. 1 (X2a or X2b). The second step can
proceed in two ways: by association with a second
homodimer to yield the homotetramer (X4) or by association
with a monomer to yield the homotrimer (X3). The reaction
is complete in the former case, but in the latter case another
monomer must be added to form the homotetramer. The
pathways that include only monomers, homodimers, and
homotetramers will be denoted MDTa and MDTb, where
‘‘MDT’’ stands for monomer-dimer-tetramer and ‘‘a’’ and
‘‘b’’ indicate the type of homodimer formed. The pathways
that include monomers, homodimers, homotrimers, and
homotetramers will be denoted MDRT, which stands for
monomer-dimer-trimer-tetramer. The italicized lower case
letters (a–g) next to the arrows in Fig. 1 are the association
rate constants. The Greek letters next to the association rate
constants are the rate constants relative to a, the rate constant
for the formation of dimer a from two monomers (b ¼ b/a,
etc.).
Mechanistic studies of homotetramer formation have been
carried out for many proteins (Jaenicke, 1987; Jaenicke and
Lilie, 2000), including dihydrofolate reductase (Bodenreider
et al., 2002), the potassium channel Kv1.3 (Tu and Deutsch,
1999), p53 (Mateu et al., 1999), b-galactosidase (Nichtl et al.,
1998), pyruvate oxidase (Risse et al., 1992), glyceraldehyde-
3-phosphate dehydrogenase (Rehaber and Jaenicke, 1992),
human platelet factor 4 (Chen and Mayo, 1991), phospho-
fructokinase (Bras et al., 1989; Deville-Bonne et al., 1989;
Martel and Garel, 1984; Teschner and Garel, 1989),
phosphoglycerate mutase (Hermann et al., 1985, 1983b),
and especially lactate dehydrogenase (Bernhardt et al., 1981;
Girg et al., 1983; Hermann et al., 1983a, 1981, 1982;
Jaenicke, 1974; Rudolph et al., 1977, 1979; Rudolph and
Jaenicke 1976; Tenenbaum-Bayer and Levitzki, 1976;
Zettlmeissl et al., 1979). All of the proteins listed above
have been found to assemble by a single MDT pathway; that
is, only one type of homodimer has ever been found to be
on the tetramerization pathway, and kinetically signiﬁcant
amounts of homotrimer have never been observed, excluding
the possibility of an MDRT mechanism (Jaenicke, 1987;
Jaenicke and Lilie, 2000). To our knowledge, no homote-
trameric protein has yet been found to assemble by an
MDRT mechanism. Thus, despite there being several
tetramerization mechanisms that could proceed in parallel,
homotetramers seem to assemble exclusively by a single
MDT pathway. This raises several questions about why this
should be. Is the MDT mechanism inherently more efﬁcient
than the MDRT mechanism? That is, given comparable
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association rate constants for these two types of mechanisms,
will the MDT mechanism always outcompete the MDRT
mechanism? On the other hand, could homotetrameric
proteins have actually evolved to assemble by MDT
mechanisms? Finally, why is competition between the two
different MDT pathways not observed? To improve our
understanding of the fundamentals of protein assembly, we
address these questions in this report by modeling homote-
tramer formation as a function of the rate constants a, b, c, d,
e, f, and g.
MATERIALS AND METHODS
Numerical integration of differential equations and other calculations were
performed on a personal computer with dual AMD Athlon 2200 MP
processors using Mathematica 4.2 (Wolfram Research, Champaign, Illinois)
for Windows XP.
RESULTS
We are primarily interested in proteins for which tetrame-
rization is favorable, even at submicromolar concentrations.
The scheme shown in Fig. 1 is therefore applicable only to
homotetrameric proteins in which the interactions along both
interfaces are strong enough for each association step to be
irreversible. In addition, to make the system tractable, we
assume that there are no kinetically signiﬁcant, unimolecular
folding or reorganization steps. For example, when tetrame-
rization is initiated from the completely unfolded and
monomeric state of the protein (often by dilution from high
concentrations of urea or guanidinium hydrochloride), then
the scheme in Fig. 1 would only be appropriate if folding of
the protein to form structured monomers were fast enough
relative to association to make it kinetically insigniﬁcant.
This is often true when protein association is relatively slow
(at low protein concentrations) (Jaenicke, 1987), although
proline isomerization can sometimes cause folding to be
slow enough that it cannot be disregarded (Bodenreider et al.,
2002). Unimolecular reorganization or folding of the protein
after dimer-, trimer- or tetramerization must also be fast
relative to association. Although such reorganization steps
have sometimes been observed experimentally, their impor-
tance is also minimized at low protein concentration
(Jaenicke, 1987; Schreiber, 2002).
The rate equations that deﬁne the kinetics of the system
are:
d½X
dt
¼2a½X22b½X2c½X2a½Xd½X2b½Xg½X3½X
(1)
d½X2a
dt
¼ a½X2  c½X2a½X  2e½X2a2 (2)
d½X2b
dt
¼ b½X2  d½X2b½X  2f ½X2b2 (3)
d½X3
dt
¼ c½X2a½X1 d½X2b½X  g½X3½X (4)
d½X4
dt
¼ e½X2a21 f ½X2b21 g½X3½X; (5)
where the brackets indicate the molar concentration of the
enclosed species and t is time in seconds. Conservation of
mass dictates that
½Xtot ¼ ½X1 2½X2a1 2½X2b1 3½X31 4½X4; (6)
where [X]tot is the total concentration of protein subunits.
Since we are concerned with homotetramer assembly
starting from a pool of monomer, the initial conditions are
½Xt¼0 ¼ ½Xtot; ½X2at¼0 ¼ ½X2bt¼0 ¼ ½X3t¼0 ¼ ½X4t¼0 ¼ 0:
(7)
FIGURE 1 Pathways for the assembly of a ‘‘dimer-of-
dimers’’-type homotetramer. The two types of interfaces
along which interactions can occur are indicated in red and
blue. Assembly begins with a monomer (X), which
dimerizes in one of two ways: along the red interface to
form homodimer a (X2a) or along the blue interface to
form homodimer b (X2b). These homodimers can then
associate to form the homotetramer (X4), or they can
successively add two monomers to form the homotrimer
(X3), then the homotetramer. The pathway that proceeds
from monomer to homodimer a to the homotetramer is the
MDTa pathway, the one that proceeds from monomer to
homodimer b to the homotetramer is the MDTb pathway,
and the one the proceeds frommonomer to homodimer a or
b to homotrimer to homotetramer is the MDRT pathway.
The italicized letters next to the arrows (a–g) are the rate
constants for the corresponding steps. The Greek letters in
parentheses are the rate constants relative to a (for
example, b ¼ b/a, x ¼ c/a, and so on).
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We have found the following transformations to be
convenient:
x¼ ½X½Xtot
; x2a¼ 2½X2a½Xtot
; x2b¼ 2½X2b½Xtot
;
x3¼ 3½X3½Xtot
; x4¼ 4½X4½Xtot
:
Thus, the new concentration variables are the mole
fractions of protein occupying a given oligomerization
state. It is also useful to change the time variable to t ¼
t3a3[X]tot. Because the units of t are s, those of [X]tot are
M, and those of a are M1s1, the new time variable, t, is
dimensionless. With the transformed variables, Eqs. 1–5
become
dx
dt
¼ 2x2  2bx2  1
2
xx2ax  1
2
dx2bx  1
3
gx3x (8)
dx2a
dt
¼ 2x2  xx2ax  ex22a (9)
dx2b
dt
¼ 2bx2  dx2bx  fx22b (10)
dx3
dt
¼ 3
2
xx2ax1
3
2
dx2bx  gx3x (11)
dx4
dt
¼ ex22a1fx22b1
4
3
gx3x; (12)
where, as indicated in Fig. 1, the lowercase Greek letters
are dimensionless, relative rate constants: b ¼ b/a, x ¼
c/a, d ¼ d/a, e ¼ e/a, f ¼ f/a, and g ¼ g/a. The
expression for mass conservation in terms of these
variables is
1 ¼ x1 x2a1 x2b1 x31 x4 (13)
and the initial conditions are
xt¼0 ¼ 1; x2a;t¼0 ¼ x2b;t¼0 ¼ x3;t¼0 ¼ x4;t¼0 ¼ 0: (14)
The total protein concentration does not appear in the
transformed rate equations, the conservation law, or the ini-
tial conditions. Thus, concentration affects only the time-
scale of the reaction and not the shape of the reaction
proﬁle. The same is true of the magnitudes of the rate con-
stants; only their relative values are important in determining
the course of the reaction. Concentration independence of
association kinetics after transformation of the concentration
and time variables as suggested above can be observed in
any associating system in which each step is both bimole-
cular and irreversible, from colloidal aggregation (Galina
and Lechowicz, 1998) to the aggregation of phosphogly-
cerate kinase (Modler et al., 2003).
Before addressing the complete system illustrated in Fig. 1
and described by Eqs. 8–14, some limiting cases will be
examined.
Case 1: Tetramerization through a single MDT
pathway; b 5 v 5 d 5 f 5 g 5 0
When all of the relative rate constants except e are set to zero,
the rate equations, conservation of mass, and initial con-
ditions become
dx
dt
¼ 2x2 (15)
dx2a
dt
¼ 2x2  ex22a (16)
dx4
dt
¼ ex22a (17)
1 ¼ x1 x2a1 x4 (18)
xt¼0 ¼ 1; x2a;t¼0 ¼ x4;t¼0 ¼ 0: (19)
Inspection of the rate equations reveals that steady state
(where the time derivatives of x, x2a, and x4 are all 0) can be
reached only when both x and x2a are 0, which, according to
mass conservation, also implies that all of the protein must be
homotetrameric (x4 ¼ 1).
Sets of nonlinear differential equations cannot usually be
solved. However, Eqs. 15–17 are an exception. The
solutions, ﬁrst derived by Chien (1948), are
x ¼ 1
11 2t
(20)
x2a ¼
1
11 2t
 
1 1
11 2t
 ð112eÞ1=2( )
l1
1
11 2t
 ð112eÞ1=2
 l2
(21)
x4¼ 1xx2a
¼ 1 1
112t
 

1
112t
 
1 1
112t
 ð112eÞ1=2( )
l1
1
112t
 ð112eÞ1=2
 l2;
(22)
where l1 ¼ ð1=2Þ 11ð112eÞ1=2
n o
and l2 ¼ ð1=2Þ 1f
ð11 2eÞ1=2g: These solutions are plotted in Fig. 2 for several
values of e. This parameter does not affect the time
dependence of x (the mole fraction of monomer), as is
evident from Eq. 20 and from Fig. 2, in which a single red
curve represents the disappearance of monomer at all values
of e. It does, however, affect the time dependencies of x2a and
x4. The amount of homodimer that builds up (and the
corresponding lag in homotetramer formation) decreases
as the relative rate constant for homotetramer formation, e,
increases. Thus, when e is 0.1, x2a reaches a maximum of
0.74 and x4 does not reach 0.1 until t ¼ 2.5, but when e is 10,
the maximum value of x2a is only 0.26 and x4 reaches 0.1
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when t ¼ 0.3. As noted above, however, all of the protein
eventually becomes homotetramer no matter what the value
of e is (x4 ! 1 as t ! ‘).
Case 2: Tetramerization through competing
MDT pathways; v 5 d 5 g 5 0
Setting x, d, and g equal to 0 reﬂects the case in which the
dimerization pathways can compete with one another. The
rate equations, conservation of mass, and initial conditions
are
dx
dt
¼ 2ð11bÞx2 (23)
dx2a
dt
¼ 2x2  ex22a (24)
dx2b
dt
¼ 2bx2  fx22b (25)
dx4
dt
¼ ex22a1fx22b (26)
1 ¼ x1 x2a1 x2b1 x4 (27)
xt¼0 ¼ 1; x2a;t¼0 ¼ x2b;t¼0 ¼ x4;t¼0 ¼ 0: (28)
Again, inspection of Eqs. 23–26 shows that steady state can
be reached only when x, x2a, and x2b are all 0, that is, when all
of the protein is homotetrameric (x4 ¼ 1).
These equations are similar to Eqs. 15–19, whose
solutions were given above. For example, replacing the
factor 2 in Eq. 15 with 2(1 1 b) yields Eq. 23. The
solution for x is therefore
x ¼ 1
11 2ð11bÞt : (29)
The availability of a second pathway causes the rate of
disappearance of x to increase by a factor of 1 1 b but
does not change its hyperbolic dependence on t.
Equations 24 and 25 have the same form as Eq. 16.
They can therefore be solved by the same method,
yielding
where m1 ¼ ð1=2Þ

11ð11ð2e=ð11bÞ2ÞÞ1=2g and m2 ¼
ð1=2Þ1 ð11ð2e=ð11bÞ2ÞÞ1=2g; and
where n1 ¼ ð1=2Þ

11ð11ð2bf=ð11bÞ2ÞÞ1=2g and n1 ¼
ð1=2Þ 1 11ð2bf=ð11bÞ2ÞÞ1=2g: The solution for x4
can then be obtained by rearranging Eq. 27:
x4 ¼ 1 x  x2a  x2b; (32)
where x, x2a, and x2b are as given in Eqs. 29–31. These
solutions can be used to understand how tetramerization
progresses when two different MDT-type pathways operate
x2a ¼ 1
11b
  1
11 2ð11bÞt
 
1 1
11 2ð11bÞt
 ð11ð2e=ð11bÞ2ÞÞ1=2( )
m1
1
11 2ð11bÞt
 ð11ð2e=ð11bÞ2ÞÞ1=2
m2;
(30)
x2b ¼ b
11b
  1
11 2ð11bÞt
 
1 1
11 2ð11bÞt
 ð11ð2bf=ð11bÞ2ÞÞ1=2( )
n1
1
11 2ð11bÞt
 ð11ð2bf=ð11bÞ2ÞÞ1=2
n2;
(31)
FIGURE 2 Plots of x, x2a and x4 as a function of t at three different values
of e for case 1, in which tetramerization proceeds through a single MDT
pathway. The single, solid red line corresponds to x, the time dependence of
which does not change with e. The three green lines represent x2a at e ¼ 0.1
(solid ), 1 (dashed ), and 10 (dotted ). The three blue lines represent x4 at e ¼
0.1 (solid ), 1 (dashed ), and 10 (dotted ).
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in parallel. For example, the solutions show that tetrameriza-
tion can be distinctly biphasic when the tetramerization rate
constants (e and f) for the two pathways are very different,
and that a substantial amount of homodimer (temporarily)
accumulates in the pathway with the lower tetramerization
rate constant. This is illustrated in Fig. 3, where x, x2a, x2b, and
x4 are plotted against twhenb¼ 1, e¼ 1, andf¼ 0.01 (upper
left), 0.1 (upper right) or 1 (lower left). The time dependence
of x4 for the various values of f is also shown in the lower
right-hand panel of Fig. 3 with t on a logarithmic scale to
emphasize the biphasic accumulation of homotetramer, and
to show that x4 ! 1 as t ! ‘ for all three values of f.
The solutions found above, though useful, are not
informative as to how much each pathway contributes to
the total amount of homotetramer formedwhen the reaction is
complete. The contributions from each pathway can be
separated and quantiﬁed by noting that, according to Eq. 26,
x4 ¼
ðt
0
ðex22a1fx22bÞdt9 ¼
ðt
0
ex22a dt91
ðt
0
fx
2
2b dt9: (33)
The contributions from the MDTa and MDTb pathways, x4a
and x4b respectively, are
x4a ¼
ðt
0
ex22a dt9; x4b ¼
ðt
0
fx22b dt9: (34)
These expressions cannot be integrated directly, but explicit
solutions for x4a and x4b can still be found as shown in the
Appendix. They are
where m1, m2, n1, and n2 are as deﬁned above. The values of
x4a and x4b as t ! ‘, which represent the amount of homo-
tetramer formed through each MDT pathway, are 1/(1 1 b)
and b/(1 1 b), respectively. Thus, the contributions of the
two pathways depend purely onb, the relative rate constant of
FIGURE 3 Plots of x, x2a, x2b, and x4
as a function of t at b¼ 1, e¼ 1, and f
¼ 0.01 (upper left), 0.1 (upper right),
and 1 (lower left) for case 2, in which
the MDTa and MDTb pathways com-
pete with each other. In these three
plots, the solid red line represents x, the
solid green line represents x2a, the
dashed green line represents x2b, and
the solid blue line represents x4 (note
that the curves for x2a and x2b overlay
when f¼ 1, so they are represented by
a single green line). The plot in the
lower right shows x4 versus t at f ¼
0.01, 0.1, and 1 with t on a logarithmic
scale.
x4a ¼ 1
11b
1 1
11 2ð11bÞt 
1
11 2ð11bÞt
 
1 1
11 2ð11bÞt
 ð11ð2e=ð11bÞ2ÞÞ1=2( )
m1
1
11 2ð11bÞt
 ð11ð2e=ð11bÞ2ÞÞ1=2
m2
0
BBBBB@
1
CCCCCA (35)
x4b ¼ b
11b
1 1
11 2ð11bÞt 
1
11 2ð11bÞt
 
1 1
11 2ð11bÞt
 ð11ð2bf=ð11bÞ2ÞÞ1=2( )
n1
1
11 2ð11bÞt
 ð11ð2bf=ð11bÞ2ÞÞ1=2
n2
0
BBBBB@
1
CCCCCA; (36)
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dimerization. When b is small, the formation of homodimer
b is relatively slow, and tetramerization occurs almost
exclusively through the MDTa pathway (x4a ! 1, x4b ! 0).
When b is large, the formation of homodimer b is relatively
fast, and tetramerization occurs almost exclusively through
the MDTb pathway (x4a ! 0, x4b ! 1). This is intuitively
satisfying; since reverse reactions have been neglected,
dimerization irreversibly commits material to one pathway
or the other, and the contribution of each pathway should
therefore depend only on the relative rates of dimerization.
Case 3: Tetramerization through an MDRT
pathway; b 5 d 5 e 5 f 5 0
Setting b, d, e, and f to 0 eliminates all of the terms in Eqs.
8–12 in which the mole fraction of monomer, x, does not
occur. Since x is a multiplier in every remaining term, the
rate equations can be simpliﬁed by another transformation of
the time variable. Let
s ¼
ðt
0
x dt9: (37)
Variables like s are known as concentration-time integrals
(Saville, 1971). Under this transformation, ds ¼ x dt and the
rate equations become
dx
ds
¼ 2x  1
2
xx2a  1
3
gx3 (38)
dx2a
ds
¼ 2x  xx2a (39)
dx3
ds
¼ 3
2
xx2a  gx3 (40)
dx4
ds
¼ 4
3
gx3: (41)
The conservation of mass and initial conditions are
1 ¼ x1 x2a1 x31 x4 (42)
xs¼0 ¼ 1; x2a;s¼0 ¼ x3;s¼0 ¼ x4;s¼0 ¼ 0: (43)
Before transformation of t, the rate equations for assembly
would not have been analytically solvable. Transformation
of t according to Eq. 37, however, converts Eqs. 38–41 to
a linear, homogeneous system of differential equations with
constant coefﬁcients. A solution in terms of the parameters x
and g could now be found in principle, but it would be
exceedingly complicated. Therefore, we present two exam-
ples at particular values of x and g to illustrate how this
system behaves. First, let x ¼ g ¼ 20, so that both tri- and
tetramerization are fast relative to dimerization. The
solutions, shown below, are simple sums of exponentials
(because the system’s eigenvalues and all of the components
of its eigenvectors are real):
x ¼ 0:07e23:8s  0:58e13s1 1:51e5:2s (44)
x2a ¼ 0:04e23:8s  0:16e13s1 0:2e5:2s (45)
x3 ¼ 0:3e23:8s  0:71e13s1 0:41e5:2s (46)
x4 ¼ 1 0:33e23:8s1 1:45e13s  2:12e5:2s: (47)
These solutions are plotted in the upper panel of Fig. 4,
which shows that x4 ! 1, and x, x2a, and x3 ! 0 as s, and
therefore t, approaches inﬁnity. The inset shows the plot for
x4 as a function of t with the corresponding values of s
shown in gray. The dependence on t was obtained by
inverting Eq. 37:
t ¼
ðs
0
ds9
x
: (48)
For the second example, let x ¼ g ¼ 1, so that the
formation of homodimers, homotrimers, and homotetramers
all have the same rate constants. In this case, the solutions are
not simple sums of exponentials; they have periodic
components (because the system of equations has eigenval-
ues that are complex numbers):
x ¼ 1
2
e
sðes1 cos s sin sÞ (49)
x2a ¼ esðcos s1 sin s esÞ (50)
x3 ¼ 3
2
e
sðes1 sin s cos sÞ (51)
FIGURE 4 Plots of x (red ), x2a (green), x3 (cyan), and x4 (blue) as
a function of s, the concentration-time integral, at x ¼ g ¼ 20 (upper panel )
and x ¼ g ¼ 1 (lower panel ) for case 3, in which tetramerization proceeds
exclusively through the MDRT pathway. The insets show the plots of x4 as
a function of t with the corresponding values of s in gray. Note that in the
lower plot, x crosses the abscissa at s  1.04. The meaning of this is
discussed in the text.
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x4 ¼ 2esðsinh s sin sÞ: (52)
The plot of these solutions in the lower panel of Fig. 4 has
a noteworthy feature: the value of x crosses the abscissa at s
 1.04 and becomes negative. According to Eq. 48, t must
approach inﬁnity as x approaches 0. The reaction must
therefore end at s  1.04 and the solutions for s[1.04 have
no physical meaning. At s  1.04, x4 still has not reached 1
and x2a and x3 have not reached 0. This is also apparent in the
inset, in which the time variable is converted back to t. The
homotetramer is not the exclusive product of the reaction
despite all of the steps leading to it being irreversible. This
happens because of something that is hidden by the use of
the concentration-time integral. As noted above, when b, d,
e, and f are all 0, the remaining nonzero terms in Eqs. 8–12
are multiplied by x. This means that steady state can be
achieved when x¼ 0, regardless of the values of x2a, x3, or x4.
In the case examined here where x ¼ g ¼ 1, x rapidly
approaches 0, trapping a substantial amount of protein in
the homodimer and homotrimer state (x2a,s¼ 1.04 ¼ 0.36,
x3,s¼ 1.04 ¼ 0.38). This is by no means an isolated phen-
omenon, restricted to a few unlikely values of x and g. Fig. 5
shows a plot of the ﬁnal value of x4 (x4,f) as a function of the
parameters x and g. These were determined by integrating
Eqs. 38–43 with values of x and g ranging from 0.01 to 100.
Tetramerization does not reach completion in large portions
of x, g space. In fact, tri- and tetramerization must both be
relatively fast (x, g  4 or larger) for homotetramers to
represent[90% of the product.
The phenomenon described above is a result of the
assumption that each step on the MDRT pathway is
irreversible. Strict irreversibility, however, is never attain-
able in real physical systems. Dissociation will still occur no
matter how favorable each monomer addition step is,
providing a pool of monomers, though probably at very
low concentration, that will allow the system to relax to its
predominantly homotetrameric equilibrium state. Indeed,
this is not unlike the relaxation of systems of polymerizing
proteins (for example, actin or ﬂagellin) to their equilibrium
length distributions (Oosawa and Asakura, 1975). The initial
depletion of monomers in these systems can occur in only
hours, whereas days could be needed to reach the ﬁnal
equilibrium (Oosawa and Asakura, 1975). Likewise, in
homotetramer forming systems, the redistribution of protein
among the oligomeric states is likely to be slow compared to
monomer depletion, trapping protein in incompletely
assembled homodimeric and -trimeric states until the system
can reach equilibrium (which we have assumed to be
overwhelmingly dominated by homotetramers).
Competition among MDTa, MDTb, and MDRT
pathways for tetramerization
The preceding examination of limiting cases has revealed
the following: 1), that accumulation of homodimer in MDT
mechanisms requires that tetramerization be slow relative
to dimerization; 2), that tetramerization can proceed in two
distinct phases, and at least one type of homodimer can
accumulate, when the MDTa and MDTb pathways compete
and the two tetramerization rate constants (e and f) are
very different; 3), that the partitioning of protein between
the MDTa and MDTb pathways depends only on the
relative rate of dimerization; and 4), that protein can be
trapped in incompletely assembled states when tetrameri-
zation takes place through the MDRT mechanism, unless x
and g are both large. To answer the questions posed at the
end of the Introduction, we will now examine the problem,
described by Eqs. 8–14, when the MDTa, MDTb, and
MDRT mechanisms can all proceed in parallel. In
particular, we will try to deﬁne conditions under which
tetramerization proceeds exclusively by a single MDT
mechanism.
Equations 8–14 have six relative rate constants (b, x, d, e,
f, and g), which makes their direct analysis complicated.
The problem can be simpliﬁed by making some assumptions
about the values of the rate constants. The addition of
monomer to homodimer a to form homotrimer and the
addition of monomer to monomer to form homodimer b
involve association along the same interface (the blue in-
terface in Fig. 1). The rate constants for these processes
should therefore be similar, and we will assume that b ¼ x.
By analogy, we will assume that the addition of monomer to
homodimer b to form homotrimer and monomer to monomer
to form homodimer a also have the same rate constants, so
d ¼ 1. Substituting b for x and 1 for d in Eqs. 8–12 reduces
the number of rate constants to four (b, e, f, and g):
FIGURE 5 A plot of the mole fraction of homotetramer as t ! ‘ as
a function of x and g when tetramerization can only occur by the MDRT
pathway. The colors of the plot specify the value of x4,f according to the key
shown in the upper portion of the ﬁgure. In addition, the plot is projected
onto the x-, g-plane above the plot. The heavier gridlines correspond to
values of x or g increasing from 0.01 by factors of 10, as indicated along the
edges of the projection. The lighter gridlines correspond to increases by
a factor of ;1.6 (100.2).
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dx
dt
¼ 2x2  2bx2  1
2
bx2ax  1
2
x2bx  1
3
gx3x (53)
dx2a
dt
¼ 2x2  bx2ax  ex22a (54)
dx2b
dt
¼ 2bx2  x2bx  fx22b (55)
dx3
dt
¼ 3
2
bx2ax1
3
2
x2bx  gx3x (56)
dx4
dt
¼ ex22a1fx22b1
4
3
gx3x: (57)
This assumption does not affect the mass balance or the
initial conditions, which are represented by Eqs. 13 or 14,
respectively. The problem can be further constrained by
noting that protein-protein association rates generally fall in
the range from 104 M1s1 to 106 M1s1 (Schreiber, 2002).
It will therefore be assumed that the rate constants for any
step are no more than 100 times more or less than a, the
(absolute) rate constant for the formation of homodimer a.
Thus, 0.01 # b, e, f, g # 100.
Answering the questions from the introduction requires
that the contributions from the MDTa, MDTb, and MDRT
pathways to the total amount of homotetramer formed at the
end of the reaction be determined as functions of the relative
rate constants. The contributions from the three pathways
can be separated by noting that, according to Eq. 57,
x4;f ¼
ð‘
0
ðex22a1fx22b1
4
3
gx3xÞdt
¼
ð‘
0
ex22a dt1
ð‘
0
fx
2
2b dt1
ð‘
0
4
3
gx3x dt: (58)
Thus,
x4a;f ¼
ð‘
0
ex22a dt; x4b;f ¼
ð‘
0
fx
2
2b dt; x4r;f ¼
ð‘
0
4
3
gx3x dt;
(59)
where x4,f is the ﬁnal mole fraction of homotetramer formed
through all pathways combined, and x4a,f, x4b,f, and x4r,f are
the ﬁnal mole fractions of homotetramer formed through the
MDTa, MDTb, and MDRT pathways, respectively.
Equations 53–57 and 13 and 14 cannot be solved
explicitly, and must therefore be numerically integrated. To
determine the dependence of x4a,f, x4b,f, x4r,f, and x4,f on the
relative rate constants, numerical solutions were obtained to
very large values of t (t ¼ 108) for combinations of b, e, f,
and g, where each was allowed to vary from 0.01 to 100 by
factors of 100.5 (;3.2). Thus, solutions were obtained for
6561 combinations of b, e, f, and g, and the results for
b ¼ 0.01, 0.1, 1, 10. and 100 are shown in Fig. 6 (the plots
for b ¼ 0.032, 0.32, 3.2. and 32 are omitted for clarity). The
ﬁve groups of plots in Fig. 6 show the contour surfaces of
x4a,f, x4b,f, x4r,f, and x4,f in the three-dimensional space
deﬁned by e, f, and g. Each contour represents the
interpolated surface of e, f, and g values on which x4a,f,
x4b,f, x4r,f, or x4,f has a particular ﬁxed value. The color of the
surface indicates the value according to the key shown in the
ﬁrst panel of Fig. 6. As mentioned above, the groups of plots
in Fig. 6 have one plot each for x4a,f, x4b,f, and x4r,f. There is
also a plot for x4,f, the mole fraction of homotetramer that
forms from all of the pathways combined. Because all of the
steps are irreversible, one might expect that x4,f should
always be 1, independent of the values of b, e, f, and g.
However, as was observed for case 3 (where the MDRT
pathwaywasconsideredby itself), proteinassembling through
the MDRT pathway can be trapped as homodimer or -trimer
before becoming homotetrameric. Indeed, inspection of Eqs.
53–57 reveals that steady state can be achieved when x, x2a,
and x2b are all 0. It is thus possible that x3 can be nonzero and
x4\ 1 at the end of the reaction, representing the situation
where protein is trapped as homotrimer.
Some features of the kinetics of the full system stand out
after an inspection of Fig. 6. At very low and very high
values of b (b ¼ 0.01 or b ¼ 100), a single MDT
mechanism dominates the formation of homotetramer.
Almost all of the protein becomes homotetrameric through
the MDTa pathway when b is small, or through the MDTb
pathway when b is large. This can be understood in terms
of the preceding examination of case 2 (where the MDTa
and MDTb pathways compete). There it was found that the
value of b directly determined the amount of homotetramer
formed through each pathway because the dimerization
step irreversibly committed protein to one pathway or the
other. When b was small, most of the protein assembled
through the MDTa pathway; when b was large, most of
the protein assembled through the MDTb pathway. The
same is true here, but in addition we note that small or
large values of b suppress the MDRT pathway. Since it
has been assumed that b ¼ x, the rate of homotrimer
formation by addition of monomer to homodimer a is also
slow when b is small, thus disfavoring the MDRT path-
way. Even when homotetramer formation from homodimer
a is slow (e is small), monomer is consumed so rapidly by
dimerization that none remains to make homotrimer by
addition to homodimer a. The only path left available to
homodimer a is tetramerization by the MDTa mechanism.
By analogy, the MDTb pathway is overwhelmingly favored
when b is large.
The behavior of the system is more complicated when the
value of b is neither small nor large. For example, all of the
pathways can make substantial contributions to the total
amount of homotetramer formed when b ¼ 1, depending on
the values of e, f, and g. The plot of x4a,f shows that the
contribution from the MDTa pathway varies from under 30%
to over 40% (0.2\x4a,f\0.5). The contours show that e has
the strongest inﬂuence on x4a,f. This should be expected,
since e is the relative rate constant for one of the steps on the
MDTa pathway (homotetramer formation from homodimer
a). In contrast, the other two relative rate constants, f and g,
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have much weaker effects on x4a,f. This can be rationalized
by noting that the steps to which these rate constants
correspond are neither on nor in direct competition with the
MDTa pathway. Analogous observations can be made on the
plot of x4b,f for b ¼ 1: f is the most inﬂuential rate constant
in this case, whereas the effects of e and g are small by
comparison.
The plot of x4r,f for b ¼ 1 shows that the contribution of
the MDRT pathway to homotetramer formation can vary
from under 10% to over 40% (0 \ x4r,f \ 0.5), again
depending on e, f, and g. For large values of g (above the
red contour), x4r,f is largest when e and f are both small.
This occurs because slow homodimer-homodimer associ-
ation rates (small values of e and f) cause both
homodimer a and b to accumulate, which gives them the
opportunity to enter the MDRT pathway by associating
with monomer to form homotrimer. Large values of g then
guarantee that the homotrimer will go on to form
homotetramer. On the other hand, when e and f are both
large, neither type of homodimer accumulates, and the
MDRT mechanism is suppressed; in fact, x4r,f is held to
\0.2 when e ¼ f ¼ 100. This is expected based on the
results of case 1, where it was found that the extent and
duration of homodimer accumulation decreased as the rate
FIGURE 6 Three-dimensional contour plots
of the total amounts of homotetramer formed
through the MDTa pathway (x4a,f), the MDTb
pathway (x4b,f), the MDRT pathway (x4r,f), and
all three pathways combined (x4,f) when all of
the pathways compete with each other for
values of b between 0.01 and 100. Each
contour represents a surface on which x4a,f,
x4b,f, x4r,f, or x4,f is constant in the space
deﬁned by the values of e, f, and g at
a particular value of b (the value of b is
shown in the center of each group of ﬁve plots)
The colors of the contours indicate the values
of x4a,f, x4b,f, x4r,f, and x4,f according to the key
in the ﬁrst panel of the ﬁgure. The plots that are
ﬁlled with a single, solid color indicate that the
mole fraction of interest is either\0.1 (red ) or
[0.9 (violet) at all values of e, f, and g. For
plots that have only one contour, the value on
either side of the contour is indicated in a gray
ellipse. Note that the total amount of homote-
tramer formed at the end of the assembly
reaction (x4,f) can be \1, even though each
individual step has been assumed to be
irreversible, because protein can be trapped
as homotrimer (see text for a discussion).
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constant for homotetramer formation increased. When
either e or f is large whereas the other is small, an
intermediate situation is observed. The formation of
homotrimer, and thus access to the MDRT pathway, is
suppressed for one homodimer (the one with the large
tetramerization rate constant), whereas it is promoted for
the other homodimer. This effect is related to the biphasic
homotetramer formation noted in case 2, but here the slow-
associating homodimer is diverted to the MDRT pathway
instead of slowly forming homotetramer. For small values
of g (below the red contour in the plot of x4r,f for b ¼ 1),
the contribution of the MDRT mechanism to homotetramer
formation is small (x4r,f\ 0.1). Instead, large amounts of
protein become trapped as homotrimer. This is evident in
the plot of x4,f for b ¼ 1, from which it is apparent that
x4,f can be\0.6, and therefore that x3 can be[0.4, at the
end of the reaction. The amount of protein trapped as
homotrimer at a given value of g is largest when e and f
are both small, smallest when they are both large, and
intermediate when one is small and one is large.
The information in Fig. 6 can be summarized as follows.
The contribution of the MDTa pathway to the total amount
of homotetramer formed, represented by x4a,f, is largest
when b is small (\0.1). Its contribution rapidly decreases
as b increases, becoming\0.1 at all values of e, f, and g
when b $ 10. The contribution of the MDTb pathway to
the total amount of homotetramer formed shows the
opposite behavior, being largest when b is large ([10)
and decreasing rapidly as b decreases. The MDTb pathway
is negligible when b # 0.1. The contribution of the MDRT
pathway is largest when b is close to 1 (0.1\ b\ 10), e
and f are both small, and g is large. Finally, the amount of
protein that becomes trapped as homotrimer is largest when
b is close to 1 (0.1\ b\ 10), e and f are both small, and
g is small.
DISCUSSION
The preceding results allow us to suggest some answers
to the questions raised in the introduction, which were as
follows: Given comparable association rate constants for
these two types of mechanisms, does the MDT mechanism
always outcompete the MDRT mechanism? Could homote-
trameric proteins have evolved to assemble by MDT
mechanisms? And, why is competition between the two
different MDT pathways not observed?
The MDT pathway does not outcompete the
MDRT pathway given comparable association
rate constants
The plots in Fig. 6 show that similar amounts of
homotetramer are produced by all of the available pathways
when their rate constants are comparable (b, e, f, and g are
all close to 1). The inherent efﬁciency of the pathways
cannot, therefore, explain the dominance of the MDT
pathway for homotetramer formation. This is consistent
with the results of Tu and Deutsch (1999), who studied the
competition between the MDT and MDRT pathways in
a system related to the one presented here (in their system,
the steps preceding tetramerization were allowed to be
reversible, but only one type of homodimer was accounted
for). They found that the MDT pathway could only be
dominant when the rate constants for monomer-monomer
and homodimer-homodimer association were large (or when
homotrimer was much more likely to revert to monomer and
homodimer than it was to add a monomer and become
homotetramer).
Homotetrameric proteins may have evolved to
favor MDT assembly mechanisms
It has been shown above that the fully formed homotetramer
is inevitably the product of the MDT pathway. This is not
necessarily true for the MDRT pathway; protein can instead
be trapped in intermediate oligomeric states. The presence of
such incompletely assembled, improper oligomers could be
harmful to an organism. For example, improper oligomers
could be susceptible to proteolysis from which the
homotetramer was protected. The protein fragments that
resulted from this proteolysis could be innocuous, in which
case the cost to the organism would only be the energy
wasted in synthesizing the protein. There is also a possibility,
however, that the presence of the protein fragments could be
detrimental. If they were amyloidogenic (prone to forming
ﬁbrillar aggregates), their aggregation could be pathogenic.
For example, aggregation by the amyloidogenic peptides that
result from the proteolysis of the amyloid precursor protein
(Hooper et al., 2000; Selkoe, 1998) and gelsolin (an actin
modulating protein) (Maury, 1991) are associated with
Alzheimer’s disease and Finnish hereditary amyloidosis,
respectively. Furthermore, improper oligomers themselves
could aggregate and lead to disease. These potentially
harmful consequences of the accumulation of improper
oligomers on the MDRT pathway could have resulted in
selective pressure favoring the MDT mechanism for
homotetramer assembly.
Competition between MDT pathways is not
observed because it would be accompanied
by competition with the MDRT pathway
The two possible MDT pathways (MDTa and MDTb in Fig.
1) can only compete when b is close to 1. This situation,
however, also favors the MDRT pathway. Thus, it could be
that competition between the MDTa and MDTb pathways is
not observed because it would always be accompanied by
a substantial contribution from the MDRT pathway, the
disadvantages of which were noted above.
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Strategies for controlling the
tetramerization pathway
Given the model for tetramerization proposed above, in
which each step is irreversible, x is set equal to b and d is
set equal to 1, Fig. 6 shows that for a single MDT pathway
to dominate homotetramer formation it is sufﬁcient (and
necessary) that b be either small (on the order of 0.01) or
large (on the order of 100). Formation of one of the two
possible homodimers must therefore be much faster than
formation of the other. This could be achieved, for example,
by optimizing the electrostatic interactions (Schreiber, 2002;
Schreiber and Selzer, 1999; Sheinerman et al., 2000) or, to
a lesser degree, the desolvation forces (Camacho et al., 2000)
at one (and only one) of the interfaces to promote fast
association. The relative importance of electrostatics and
desolvation to homotetramer formation is difﬁcult to
evaluate because, even for homotetramers that are known
to assemble by an MDT mechanism, it is not usually known
which homodimer is on the assembly pathway. An exception
is phosphofructokinase, for which the order in which subunit
interfaces form has been determined (Bras et al., 1989;
Deville-Bonne et al., 1989; Teschner and Garel, 1989). A
detailed calculation and comparison of the electrostatic
energies at the two interfaces is beyond the scope of this
article, but inspection of the crystal structure (accession no.
2PFK (Rypniewski and Evans, 1989)) does not reveal
electrostatic interactions to be obviously more important at
one interface than the other. Thus, for phosphofructokinase,
it may be desolvation forces that ensure assembly by the
MDT pathway. Nonetheless, we note that electrostatics are
generally recognized to have a stronger inﬂuence on protein-
protein association rates than desolvation (Camacho et al.,
1999; Janin, 1997; Schreiber, 2002), and that electrostatics
probably play an important role in the assembly of other
protein homotetramers.
Other ways of suppressing the MDRT pathway become
apparent if our assumption that b ¼ x is relaxed. For
example, Mateu et al. (1999) have proposed a model for the
assembly of the p53 tetramerization domain in which
monomers are initially unfolded, but simultaneously asso-
ciate and fold to yield a structured homodimer. This
homodimer can then go on to form the homotetramer.
Because folding is required to create the interface necessary
for tetramerization, b and x would be small (though not
necessarily equal to each other), making the MDRT pathway
inaccessible. Moreover, if the assumption that all of the
association steps are irreversible is relaxed, the MDT
mechanism can be enforced if only one of the two possible
homodimers is stable enough to form under tetramerization
conditions.
The ways listed above that rely on differences between
two interfaces to ensure the MDT mechanism for homote-
tramer formation cannot be used by homotetrameric proteins
that have a four-fold (C4) axis of symmetry, because all of
the interfaces are identical in such homotetramers. Neverthe-
less, Kv1.3, a potassium channel that presumably has a C4
axis of symmetry, has been found to assemble by the MDT
pathway (Tu and Deutsch, 1999). Our results do not strictly
apply to the assembly of C4 symmetrical homotetramers
because their symmetry demands that there be only one
MDT pathway for homotetramer formation, a possibility not
accounted for by the scheme in Fig. 1. Tu and Deutsch,
however, have modeled this system (Tu and Deutsch, 1999).
To explain why Kv1.3 assembles by an MDT pathway, they
have proposed a mechanism in which a conformational
change occurs after monomers associate to form homo-
dimers. This yields a homodimer with interfaces that are self-
complementary (allowing homotetramer formation) but
incompatible with those of the monomer (disfavoring the
MDRT pathway). The difference between this mechanism
and that proposed for the p53 tetramerization domain is that,
in this case, the conformational change must occur in such
a way that the C4 symmetry of the ﬁnal homotetramer can be
maintained.
In summary, we have shown that the MDT pathway for
protein homotetramer formation is fundamentally different
from the MDRT pathway in that all available protein is
eventually converted to homotetramer in the MDT pathway,
whereas substantial amounts of protein can be trapped as
assembly intermediates in the MDRT pathway. We suggest
that improper oligomers formed in the MDRT pathway could
be vulnerable to aberrant proteolysis, misfolding, and
aggregation, and that this may have led to evolutionary
pressure favoring the MDT pathway. We believe that this
may explain the uniform dominance of the MDT pathway for
homotetramer formation.
APPENDIX
To obtain explicit expressions for the contribution of the MDTa pathway in
case 2 (tetramerization through competing MDT pathways), we ﬁrst
rearrange Eq. 24:
ex22a ¼ 2x2 
dx2a
dt
: (60)
This expression for ex2a
2 can be substituted into Eq. 34:
x4a ¼
ðt
0
2x
2
dt9
ðt
0
dx2a
dt9
dt9
¼ 2
ðt
0
1
11 2ð11bÞt9
 2
dt9
ðt
0
dx2a
dt9
dt9: (61)
Integrating the expressions above yields
x4a ¼ 1
11b
1 1
11 2ð11bÞt
 
 x2a: (62)
Finally, replacing x2a according to Eq. 30 yields the time dependence for x4a:
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where m1 and m2 are as deﬁned above for Eq. 30. This is identical to Eq. 35.
The expression for x4b in Eq. 36 can be obtained in an analogous way.
We thank S. Deechongkit, C. Esau, A. Hurshman, T. Foss, and J. W. Kelly
for helpful discussions.
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